Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Designing spatial and temporal control of vaccine responses
Gillie A. Roth, Vittoria C. T. M. Picece, Ben S. Ou, et al.
Nature Reviews Materials (2021) Vol. 7, Iss. 3, pp. 174-195
Open Access | Times Cited: 211

Showing 1-25 of 211 citing articles:

Vaccine adjuvants: mechanisms and platforms
Tingmei Zhao, Yulong Cai, Yujie Jiang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 255
Self‐Assembling Peptide‐Based Hydrogels for Wound Tissue Repair
Tong Guan, Jiayang Li, Chunying Chen, et al.
Advanced Science (2022) Vol. 9, Iss. 10
Open Access | Times Cited: 182
Machine Learning Methods for Small Data Challenges in Molecular Science
Bozheng Dou, Zailiang Zhu, Ekaterina Merkurjev, et al.
Chemical Reviews (2023) Vol. 123, Iss. 13, pp. 8736-8780
Open Access | Times Cited: 144
Virus-Like Particles: Revolutionary Platforms for Developing Vaccines Against Emerging Infectious Diseases
Hasnat Tariq, Sannia Batool, Saaim Asif, et al.
Frontiers in Microbiology (2022) Vol. 12
Open Access | Times Cited: 136
Polymeric Nanoparticles for Drug Delivery
Maximilian A. Beach, Umeka Nayanathara, Yanting Gao, et al.
Chemical Reviews (2024) Vol. 124, Iss. 9, pp. 5505-5616
Closed Access | Times Cited: 122
A Peritumorally Injected Immunomodulating Adjuvant Elicits Robust and Safe Metalloimmunotherapy against Solid Tumors
Lingxiao Zhang, Jing Zhao, Xi Hu, et al.
Advanced Materials (2022) Vol. 34, Iss. 41
Closed Access | Times Cited: 104
Boosting Checkpoint Immunotherapy with Biomaterials
Lujie Liu, Yuanwei Pan, Chenchen Zhao, et al.
ACS Nano (2023) Vol. 17, Iss. 4, pp. 3225-3258
Closed Access | Times Cited: 55
Microneedle-Mediated Transdermal Delivery of Biopharmaceuticals
Hiep X. Nguyen, Chien Ngoc Nguyen
Pharmaceutics (2023) Vol. 15, Iss. 1, pp. 277-277
Open Access | Times Cited: 52
Biomaterials Facilitating Dendritic Cell‐Mediated Cancer Immunotherapy
Heng Dong, Qiang Li, Yu Zhang, et al.
Advanced Science (2023) Vol. 10, Iss. 18
Open Access | Times Cited: 43
Dendritic Cell Vaccines: A Shift from Conventional Approach to New Generations
Kyu-Won Lee, Judy Wai Ping Yam, Xiaowen Mao
Cells (2023) Vol. 12, Iss. 17, pp. 2147-2147
Open Access | Times Cited: 39
Lymph-targeted high-density lipoprotein-mimetic nanovaccine for multi-antigenic personalized cancer immunotherapy
Mingqi Liu, Yang Feng, Yougong Lu, et al.
Science Advances (2024) Vol. 10, Iss. 11
Open Access | Times Cited: 22
Interactions between nanoparticles and lymphatic systems: Mechanisms and applications in drug delivery
Yisi Tang, Bao Liu, Yuting Zhang, et al.
Advanced Drug Delivery Reviews (2024) Vol. 209, pp. 115304-115304
Closed Access | Times Cited: 17
Bringing immunofocusing into focus
Sriharshita Musunuri, Payton A. Weidenbacher, Peter S. Kim
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 16
Engineered Bio‐Based Hydrogels for Cancer Immunotherapy
Yuxuan Peng, Shuang Liang, Qian‐Fang Meng, et al.
Advanced Materials (2024) Vol. 36, Iss. 21
Closed Access | Times Cited: 14
Cascade Carrier‐Free Nanoparticles Forming In Situ Nanovaccines for Synergistic Photothermal‐Immunotherapy of Cancer
Chenlu Huang, Hanyong Wang, Xinyu Yang, et al.
Advanced Functional Materials (2024) Vol. 34, Iss. 29
Closed Access | Times Cited: 13
Dissolvable polymer microneedles for drug delivery and diagnostics
Masood Ali, Sarika Namjoshi, Heather A. E. Benson, et al.
Journal of Controlled Release (2022) Vol. 347, pp. 561-589
Closed Access | Times Cited: 62
In situ generation of micrometer-sized tumor cell-derived vesicles as autologous cancer vaccines for boosting systemic immune responses
Yuxin Guo, Shaozhe Wang, Xinping Zhang, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 60
Sustained delivery approaches to improving adaptive immune responses
Ben S. Ou, Olivia M. Saouaf, Julie Baillet, et al.
Advanced Drug Delivery Reviews (2022) Vol. 187, pp. 114401-114401
Open Access | Times Cited: 54
Polymeric nanoparticle-based nanovaccines for cancer immunotherapy
Yongxin Zhang, Jiajing Chen, Linqi Shi, et al.
Materials Horizons (2022) Vol. 10, Iss. 2, pp. 361-392
Closed Access | Times Cited: 46
Three-dimensional (3D) scaffolds as powerful weapons for tumor immunotherapy
Shuyan Han, Jun Wu
Bioactive Materials (2022) Vol. 17, pp. 300-319
Open Access | Times Cited: 39
Lysosomal-mediated drug release and activation for cancer therapy and immunotherapy
Yinping Sun, Yongjie Sha, Guanhong Cui, et al.
Advanced Drug Delivery Reviews (2022) Vol. 192, pp. 114624-114624
Closed Access | Times Cited: 36
Self-adjuvanting cancer nanovaccines
Zhiyun Liao, Jing Huang, Pui‐Chi Lo, et al.
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 35
Protein-Based Adjuvants for Vaccines as Immunomodulators of the Innate and Adaptive Immune Response: Current Knowledge, Challenges, and Future Opportunities
Diego A. Díaz-Dinamarca, Michelle L. Salazar, Byron N. Castillo, et al.
Pharmaceutics (2022) Vol. 14, Iss. 8, pp. 1671-1671
Open Access | Times Cited: 35
Multiplexed strategies toward clinical translation of extracellular vesicles
Junying Song, Baoqiang Song, Lijun Yuan, et al.
Theranostics (2022) Vol. 12, Iss. 15, pp. 6740-6761
Open Access | Times Cited: 35
Chiral polypeptide nanoparticles as nanoadjuvants of nanovaccines for efficient cancer prevention and therapy
Yuanzhen Su, Weiguo Xu, Qi Wei, et al.
Science Bulletin (2023) Vol. 68, Iss. 3, pp. 284-294
Closed Access | Times Cited: 34
Page 1 - Next Page

Scroll to top